Before treatment | Post Treatment | t-test(p-value) | ||
---|---|---|---|---|
TACE + Sunitinib group | Bilirubin(µmol/L) | 12.3 ± 2.6 | 16.1 ± 4.8 | < 0.001 |
Albumin(g/L) | 37.62 ± 2.42 | 35.76 ± 5.41 | 0.091 | |
BUN(mmol/L) | 6.34 ± 1.43 | 7.71 ± 0.89 | < 0.001 | |
Cr(µmol/L) | 87.4 ± 21.1 | 110.3 ± 20.8 | < 0.001 | |
GFR(ml/min) | 107.06 ± 8.29 | 95.78 ± 12.97 | < 0.001 | |
WBC(G/L) | 4.43 ± 0.72 | 6.92 ± 0.72 | < 0.001 | |
RBC(T/L) | 4.39 ± 0.44 | 3.64 ± 0.66 | < 0.001 | |
PLT(G/L) | 128.81 ± 19.93 | 95.40 ± 18.03 | < 0.001 | |
Sunitinib group | Bilirubin(µmol/L) | 11.4 ± 3.0 | 15.0 ± 5.3 | < 0.001 |
Albumin(g/L) | 38.42 ± 3.37 | 33.37 ± 3.05 | < 0.001 | |
BUN(mmol/L) | 6.07 ± 1.41 | 7.54 ± 0.98 | < 0.001 | |
Cr(µmol/L) | 89.4 ± 17.7 | 105.0 ± 25.6 | < 0.001 | |
GFR(ml/min) | 104.58 ± 8.81 | 99.34 ± 12.46 | 0.023 | |
WBC(G/L) | 4.63 ± 0.62 | 3.52 ± 0.73 | < 0.001 | |
RBC(T/L) | 4.53 ± 0.58 | 3.37 ± 0.74 | < 0.001 | |
PLT(G/L) | 124.67 ± 20.31 | 87.90 ± 23.32 | < 0.001 |